News
Bilthoven Biologicals restarts production of polio vaccines
In November 2022, a Bilthoven Biologicals employee became infected with the polio virus during his work. The company then ceased activities with active polio virus. An investigation into the cause and improvement actions were successfully carried out. On February 6, the company will restart production of polio vaccines.